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Devices and methods are provided for forming a vascular 
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The device preferably comprises a stretching mechanism 
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ing a first post and a second post which are connected to the 
body; (iii) a driver element slidably secured to the body and 
disposed between the pair of posts; and (iv) a device for 
sliding the driver element away from the pair of posts to 
axially distend a blood vessel positioned between the pair of 
posts and the driver element. Preferably, the device is 
implanted, for example using endoscopic techniques, for use 
in vivo, although the device also can be used in vitro. 
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DEVICES FOR CREATING VASCULAR 
GRAFTS BY VESSEL DISTENSION USING 




Bypass Graft Surgery, American College of Cardiology/ 
American Heart Association, J. Am. Coll. Cardiol., 34( 4) 
:1262-347 (1999)) strongly recommends a move to total 
arterial revascularization. 
In some cases, autologous or homologous saphenous vein 
preserved by freezing or other processes is used. CROSS-REFERENCE TO RELATED 
APPLICATIONS 
Priority is claimed to U.S. provisional application No. 
60/274,909, filed Mar. 9, 2001, and a continuation-in-part to 
U.S. application Ser. No. 09/322,095, filed May 28, 1999, 
now U.S. Pat. No. 6,322,553, which claims priority to U.S. 
provisional application Serial No. 60/087,027, filed May 28, 
1998, all of which are incorporated herein in their entirety. 
With people living longer, multiple surgeries are more 
common. At the same time, open-heart surgery is becoming 
routine, aided by the development of new, minimally inva-
10 sive and "off-pump" procedures that have dramatically 
simplified the surgery and reduced the recovery time. 
Development of a longer lasting small-diameter vascular 
graft is the subject of much academic and industrial 
BACKGROUND OF THE INVENTION 
The present invention is generally in the area of methods 
and devices to obtain vascular tissue grafts and more spe-
cifically in the area of methods and devices to obtain grafts, 
preferably autologous grafts, prepared from living vascular 
tissue. 
15 
research. One current approach is to combine cell culture 
and biomaterials technologies to make a living, "tissue 
engineered" graft. This effort, however, is hindered by the 
requirements of a successful graft: It should be self-
rep airing, non-immunogenic, non-toxic, and non-
Vascular grafts are commonly used by surgeons to bypass 
obstructions to blood flow caused by the presence of ath-
erosclerotic plaques. Vascular grafts also are used in other 
applications such as providing arterial-venous shunts in 
dialysis patients, vascular repair or replacement and treating 
aneurysms. Grafts for bypass are often, but not exclusively, 
used in the coronary arteries, the arteries that supply blood 
20 thrombogenic. The graft also should have a compliance 
comparable to the artery being repaired, be easily sutured by 
a surgeon, and not require any special techniques or han-
dling procedures. Grafts having these characteristics are 
difficult to achieve. Despite the substantial effort to date and 
25 
the potential for significant financial reward, academic and 
industrial investigators have failed to produce graft materials 
that have demonstrated efficacy in human testing. 
to the heart. The materials used to construct a vascular graft 
usually are either synthetic or of biological origin, but 30 
combinations of synthetic and biological materials are under 
development. The most widely used biological vascular 
grafts are autologous saphenous vein or mammary artery. 
Some common synthetic grafts are made of polytetrafluo-
roethylene (PTFE) (e.g., GORTEX™) or polyester (e.g., 35 
DACRON™). Autologous grafts have generally been used 
more successfully than synthetic grafts. Autologous grafts 
remain patent (functional) much longer than synthetic grafts, 
and saphenous veins often fail in less than five years. The 
short lifetime of synthetic grafts is especially evident with 40 
small diameter (less than 7 mm diameter) grafts, as most 
small diameter synthetic grafts occlude within one to two 
years or less. 
Efforts to avoid or minimize the need for vascular grafts 
for repair of otherwise healthy vascular tissue have been 
described. For example, Ruiz-Razura et al., J. Reconstruc-
tive Microsurgery, 10(6):367-373 (1994) and Stark et al., 
Plastic and Reconstructive Surgery, 80(4):570-578 (1987) 
disclose the use of a round microvascular tissue expander for 
acute arterial elongation to examine the effects on the tissue 
of such acute hyperextension. The expander is a silicone 
balloon that is placed under the vessel to be elongated. The 
balloon is filled with saline over a very short period, causing 
acute stretching and elongation of the vessel. The method is 
purported to be effective for closure of arterial defects up to 
30 mm without the need for a vein graft. These techniques 
are appropriate for trauma, but are not used for restoring 
blood flow in vessels that are occluded, for example by 
disease, which are treated by surgically bypassing the 
obstruction with a graft. The disclosed methods and devices 
fail to provide an autologous graft or versatile substitute. 
Moreover, the acute stretching may damage the vessel. 
It is therefore an object of the present invention to provide 
devices and methods for creating natural blood vessel suit-
able for grafting. 
It is another object of the present invention to provide 
devices and methods for making an autologous blood vessel 
graft. 
It is further object of the present invention to provide 
devices and methods for creating blood vessel grafts in vivo 
55 or in vitro. 
Small diameter vascular grafts are particularly used in 
coronary artery bypass surgery. Internal mammary artery 45 
(IMA) is the autologous graft of choice, because it typically 
has a longer life than venous grafts (95% patent at 5 years 
versus 85% patent at 2 years). Mammary arterial tissue, 
however, is difficult to harvest, typically is not available in 
lengths sufficient for multiple bypasses, and its removal can 50 
result in problems such as problematic wound healing. 
Moreover, obtaining sufficient venous tissue for repairing an 
occluded artery can be problematic in patients with venous 
conditions such as varicose veins and especially in second or 
third surgeries in the same patient. Recent literature also 
suggests that IMA used in bypass procedures either fails 
soon after transplantation or remains patent indefinitely. See, 
e.g., Bergsma, et al., Circulation 97(24):2402--05 (1998); 
Cooley, Circulation 97(24):2384-85 (1998). Other arteries 
such as the gastroepipolic, gastric, radial, and splenic also 60 
are used in coronary bypass procedures. Moreover, the 
recent American Heart Association/American College of 
Cardiology consensus document (Eagle, K.A., et al. "ACC/ 
AHA Guidelines for coronary artery bypass graft surgery: A 
report of the American College of Cardiology/American 65 
Heart Association Task Force on Practice Guidelines", Com-
mittee to Revise the 1991 Guidelines for Coronary Artery 
These and other objects, features, and advantages of the 
present invention will become apparent upon review of the 
following detailed description of the invention taken in 
conjunction with the drawings and the appended claims. 
SUMMARY OF THE INVENTION 
Devices and methods are provided for forming a vascular 
graft by axially distending a blood vessel to stimulate vessel 
growth. Preferably, the device is implanted, for example 
using endoscopic techniques, for use in vivo. A portion of a 
blood vessel (i.e. the donor vessel) then is distended using 
US 6,663,617 Bl 
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the device. Preferred donor vessels include the gastroepi-
polic artery, as well as the internal mammary, femoral, 
splenic, and radial arteries. Then, the in vivo distended 
portion of the donor vessel is excised, for example, at the 
time of bypass surgery. In an alternative embodiment, a 5 
section of donor vessel is surgically excised from the bypass 
surgery patient and then distended in vitro in a medium for 
cell growth, e.g., in an organ culture system or bioreactor. 
Where the donor is the recipient of the graft, the result using 
either approach advantageously is a totally autologous, 10 
living vascular graft. 
In a preferred embodiment, the device comprises a 
stretching mechanism which includes (i) a rigid body; (ii) a 
pair of posts comprising a first post and a second post which 
are connected to the body; (iii) a driver element slidably 15 
secured to the body and disposed between the pair of posts; 
and (iv) a means for sliding the driver element away from 
the pair of posts to axially distend a blood vessel positioned 
between the pair of posts and the driver element. The posts 
of the device preferably have a curved lateral surface having 20 
a radius of curvature large enough to avoid collapsing the 
blood vessel during stretching 
In one variation, the body comprises a plate from which 
a pair of posts protrudes. This device may further include a 
second plate secured to the body defining a space in which 25 
the blood vessel is stretched. The posts can be integral with 
or attached to the base plate. In one embodiment, the posts 
are rotatably attached to the base plate. 
4 
to enhance growth of the blood vessel. Such agents may be 
impregnated into the materials of construction forming the 
device or can be in the form of a coating or a reservoir device 
attached to the stretching device. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a plan view of one embodiment of the device for 
vessel distension. 
FIG. 2 is a plan view of a second embodiment of the 
device for vessel distension. 
FIG. 3 is a side elevational view of the distension device 
shown attached to a donor blood vessel. 
FIGS. 4A and 4B are illustrations of a normal and 
stretched blood vessel. 
FIGS. SA-C are front (SA), plan (SB), and side (SC) 
views of one embodiment of the device for vessel distension 
using fixed points of vessel attachment. 
FIGS. 6A-C are diagrams showing vessel distension 
using an embodiment of the device having points of vessel 
attachment that are fixed relative to one another. 
FIGS. 7A-C are front (7A), plan (7B), and side (7C) 
views of one embodiment of a device for both rectilinear and 
curvilinear vessel distension. 
FIGS. 8A-B are diagrams showing vessel distension 
using one embodiment of the device for both rectilinear and 
curvilinear vessel distension. 
FIG. 9 illustrates a passive power source adaptable to 
powering the stretching device shown in FIG. 1. 
FIG. 10 is a perspective, partially exploded view of one 
preferred embodiment of a stretching device comprising a 
moveable driver element and fixed posts. 
FIGS. llA-B is a perspective view of the device in FIG. 
10 in operation. 
FIG. 12 is a perspective view of the device of FIG. 10 
wherein the driver element is controlled by a push/pull wire. 
In a more preferred, "foldable," variation, the body com-
30 
prises a pair of movable arms connecting the pair of posts to 
the body. The arms can be oriented with the length of the 
body to provide a narrow device profile to facilitate in vivo 
insertion, and then once implanted can be deployed into a 
second position, suitable for blood vessel loading and 
35 
stretching, approximately perpendicular to the longitudinal 
axis of the body. In this embodiment, the pair of moveable 
arms comprises a first arm and a second arm, each having a 
distal end and a proximal end, such that the proximal ends 
are hingedly connected to the body. The posts preferably are 
wheels rotatably attached to the distal end of each arm. 
Preferably, the body comprises a lower end portion that is 
adjustable to lock the moveable arms into two or more 
positions. The lower end portion can be biased by a spring 
FIG. 13 is a rear view of one embodiment of a stretching 
device comprising a moveable driver element and fixed 
posts, wherein the driver element movement is guided and 
40 driven by a guide rod and a spring, respectively. 
FIG. 14 is a perspective view of a preferred embodiment 
of a driver element suitable for use with a guide rod. 
to hold the lower end portion in engagement with the body. 
FIG. lS is a perspective view of one embodiment of a 
driver element having a protrusion suitable for mating with 
45 a groove or slot in the body of the device and/or a cover 
plate. 
The device typically includes a controller for controlling 
the means for sliding the driver element, in a continuous, 
intermittent, or cyclic manner. Preferably, the means for 
sliding the driver element comprises a prime mover that is 
mechanically, electromechanically, or hydraulically driven. 50 
In one embodiment, the device further comprises a guide 
rod, which passes through an aperture in the driver element 
to guide the movement of the driver element as the driver 
element is slid along the guide rod by the means for sliding. 
Other mechanisms for imparting lateral stability to the driver 55 
element include the use of a protrusion or groove that 
matingly engages with a corresponding groove in or protru-
sion from the body to guide the movement of the driver 
element as the driver element is slid by the means for sliding. 
The means for sliding the driver element can include one 60 
or more springs. These springs can provide constant stretch 
or a nonlinear or a constant force-deformation response. In 
one embodiment, the spring can comprise a shape memory 
material so the spring's stiffness or shape can be changed as 
stretching progresses or periodically. 
The device optionally can include a growth factor or other 
growth stimulating agent for release in an effective amount 
65 
FIG.16 is a perspective view of one embodiment of a base 
plate that has a recess for sealing a drive mechanism with 
another plate. 
FIG. 17A is a perspective view of one embodiment of a 
post formed to be integral with a base plate. 
FIG. 17B is a perspective view of one embodiment of a 
moveable post rotatably attached to a base plate. 
FIG. 18 is a perspective view of one embodiment of a 
resting member extending from a base plate, wherein the 
resting member includes a groove and a pin to lock the 
driver element in position. 
FIG. 19 is a perspective view of one preferred embodi-
ment of a stretching device comprising a moveable driver 
element with a pair of moveable arms and posts in the 
deployed position. 
FIGS. 20A-B illustrate the device of FIG. 19 with the 
moveable arms and posts in a folded or undeployed position. 
FIG. 21 is a plan view of one embodiment of a bottom 
plate for isolating the stretching device for surrounding 
tissue and securing the device in place in vivo. 
US 6,663,617 Bl 
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DETAILED DESCRIPTION OF IBE 
INVENTION 
It is known that smooth muscle cells, which dominate the 
media, the major load bearing layer of the arterial wall, 
proliferate and increase their production of extracellular 
matrix in response to mechanical stimulation. It was dis-
covered that this knowledge could be advantageously 
applied to create an autologous graft of appropriate diameter 
for coronary bypass or other vascular graft application using 
a distension device to stimulate angiogenesis. While an 
autologous graft is preferred, the devices and methods 
described herein also can be applied to an artery from 
another human or other animal, including transgenic animals 
genetically engineered to have tissues that will not be 
rejected by humans. The distension device can be adapted to 
operate in vivo or in vitro. 
The devices and methods described herein can used to 
make allogeneic and xenogeneic vascular grafts, as well as 
the more preferred autogeneic vascular grafts. 
Distension Device 
The distension device secures the donor blood vessel at 
different points on the vessel and then distends or stretches 
the vessel between those points to form an elongated por-
tion. The elongated portion can then be excised for use as a 
vascular graft. Stretching can be continuous, cyclical, or 
intermittent, and can occur rectilinearly, curvilinearly, or in 
a combination thereof. The stretching can occur between 
vessel attachment points that are movable relative to one 
other or in fixed positions relative to one other. 
I. Movable Attachment Positions 
The device typically includes a stretching mechanism that 
can be attached by means such as straps or sutures to the 
donor blood vessel, a means for operating the stretching 
mechanism to cause the vessel to distend (i.e. extend), and 
a controller for controlling the operating means. 
A Stretching Mechanism 
In a preferred embodiment, the distension device stretch-
ing mechanism includes a pair of opposed straps or loops 
that are fixedly attached to the donor blood vessel such as by 
sutures. The opposed straps are displaced away from each 
other over a period of time so that the donor vessel elongates 
as the straps are displaced. After a period of time, such as 
when the straps are displaced a pre-determined distance, the 
section of vessel and the device are removed and the ends of 
the donor vessel are sutured together if needed. 
The device straps should be made out of a biocompatible 
material such as a synthetic or natural polymer or metal. The 
straps must be able to be attached to the vessel, for example, 
using sutures, staples, or adhesion. Examples of suitable 
material for the straps are polytetrafiuoroethylene (PTFE), 
polyester (e.g., DACRON™), nylon (e.g., DELRIN™), 
polysulfone, polypropylene, and polyethylene. The strap 
material preferably is doped to render it radio opaque, so that 
the stretching process can be monitored using x-ray tech-
niques. The straps can be wrapped in a material that is then 
attached to the vessel, or they can include perforations or 
holes to accommodate suturing to the vessel. The straps 
preferably have a flex strength to support the distending 
force applied on the stretching mechanism. 
The device includes a means to displace the straps away 
from each other and stretch the vessel. This displacement 
can be accomplished by any of a variety of techniques. For 
example, the device can include rods attached to the straps 
that can be moved to push or pull on the straps to slowly 
displace the straps from each other. The rods can be moved, 
for example, by mechanical or hydraulic means. 
6 
B. Operating Means 
The device includes means to operate the stretching 
mechanism, preferably including a prime mover and elec-
tronic drivers for the prime mover, both of which are 
5 preferably implanted. The prime mover can be an electro-
mechanical (active) device, such as a linear motor that 
operates the stretching mechanism to push and/or pull the 
straps away from each other. A rotary motor could also be 
used to generate the required linear motion, using techniques 
10 known in the art. Alternatively, the prime mover can operate 
hydraulically. An active device generally requires input over 
time. The prime mover also can be a passive device such as 
a spring or a combination of a spring and a damper, where 
stored mechanical energy is used to push and/or pull the 
15 straps away from each other. 
Linear or rotary piezo micro-motor devices (actuators) 
deliver small step sizes, small forces, have relatively simple 
control electronics and inherent force overload protection. 
Suitable devices are available from a number of vendors, 
20 including Micro Pulse Systems, Inc. Parameters of the 
operating means include the force applied by the stretching 
mechanism, the rate and direction of movement of the 
stretching mechanism, the length of time that the stretching 
mechanism is operated, and the type of stretching applied 
25 (e.g., continuous, cyclical, or intermittent). 
C. Controller 
The controller controls the operating means. In the in vivo 
distension embodiments, the controller can include a micro-
processor that is implanted and that can be activated, 
30 programmed, or reprogrammed by an externally applied 
magnetic or electromagnetic field. The controller also can be 
activated, programmed, or reprogrammed externally using 
wires that pass through the skin, or by wireless means for 
transmitting power or data known in the art wherein wires 
35 need not pass through the skin. 
One embodiment of the device is shown in FIG. 1. 
Proximal locking strap 10 and distal locking strap 12 are of 
adjustable length appropriate for a secure fit around the 
donor blood vessel to be distended. Blood vessels range 
40 from about 0.2 to 2 cm in diameter. The locking straps 10, 
12, include a lace 14, 16, respectively, of a biocompatible 
material, such as DACRON™, that can be secured to the 
donor vessel, such as by suturing, stapling, or using an 
adhesive agent. In a preferred embodiment, the laces are 
45 designed similarly to the sewing rings of a standard artificial 
heart valve. Alternatively, a layer of a material, such as a 
fabric or film, can be attached to the strap so that the vessel 
can be sutured, stapled, or adhered to the material to hold the 
strap to the vessel. In another embodiment, the strap 
50 includes perforations, holes, or other structural features 
amenable to suturing or stapling, so that the vessel can be 
sutured or stapled directly to the strap. The locking straps 
each have a head 11, 13 with an internal aperture. Preferably, 
the straps 10, 12 include a plurality of teeth (not shown) that, 
55 when the free end of the lace 14, 16 is inserted through the 
aperture of the head of the strap, it engages the head and 
prevents the free end of the lace from becoming disengaged, 
in a manner similar to that of standard pull-ties. 
Alternatively, the head of the strap can engage the strap if the 
60 lace 14, 16 does not cover the entire strap or if the strap 
includes securing holes or perforations as described above. 
The straps optionally may be impregnated or coated with 
one or more growth stimulating agents (e.g., growth factors) 
that can be released in an effective amount to promote vessel 
65 tissue growth during the stretching procedure. 
Sliding bearings 18, 20, on straps 10, 12, respectively, and 
stops 22 and 24, respectively, can be either attached to or 
US 6,663,617 Bl 
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integrally formed (during manufacture) with the straps or 
laces as shown. The bearings and stops are preferably made 
of the same material as the straps, although other biocom-
patible materials can be used. 
A first push/pull rod 26 is fixedly attached to proximal tie 5 
strap 10 at stop 22. A second push/pull rod 28 is fixedly 
attached to distal tie strap 12 at stop 24. The two push/pull 
rods are preferably initially not fitted to the locking straps 
but are easily assembled on the device in vivo after the 
locking straps are secured around the vessel and sutured or 10 
otherwise fixed in place. The push/pull rods slide through 
the bearings 18, 20 and engage the stops 22, 24. The 
proximal locking strap 10 including the lace 14, sliding 
bearing 18, stop 22, and the fixedly attached rod 26 form a 
first integrated stretch unit 30. The distal locking strap 12 15 
including the lace 16, sliding bearing 20, stop 24, and the 
fixedly attached rod 28 form a second integrated stretch unit 
32. Push/pull rods 26, 28 are preferably made of a rigid 
material such as stainless steel, titanium or a biocompatible, 
rigid plastic. 20 
A wire (or cable) 36, preferably stainless steel or titanium, 
is fixedly attached to first push/pull rod 26 at 38 and passes 
freely through a hole 40 in push/pull rod 28. The wire 36 
then passes freely through the sheath 44 into the prime 
mover housing 46. The prime mover shown is a piezo- 25 
actuator or other linear motor. Those skilled in the art will 
8 
194. Representative examples of absorbent materials include 
synthetic hydrophilic substances, such as certain polymers, 
or natural materials, such as cellulose. Air or other gas in the 
interstices of the highly absorbent material 194 that is 
displaced by the fluid 192 exits from the piston through vent 
196. It can be seen that the piston movement provides a 
continuous driving force and linear motion to the wire or 
cable 36 in the embodiment shown in FIG. 1. The first orifice 
184 can be of a fixed size or a variable size to control the 
movement of the piston 188. For example, orifices made of 
piezoelectric or magnetostrictive materials can be made to 
selectively vary in size by the application of an appropriate 
electric or magnetic field. The spring 190 can have a linear, 
nonlinear or constant force deflection characteristic and may 
consist of multiple springs acting together and designed to 
produce the required stretching force and motion profile. 
Those skilled in the art will recognize that this device can be 
adapted to either push or pull on the cable or wire, depending 
on the arrangement of the elements. 
FIG. 2 illustrates a second embodiment 70 of a device for 
vessel distension. The hydraulic embodiment uses two 
miniature, double-acting hydraulic cylinders 72, for 
example made of stainless steel, titanium or polymer, 
through which hydraulic force is exerted to stretch the blood 
vessel by pushing on straps 10. Double acting hydraulic 
cylinders 72 are connected by a hydraulic line 74 into which 
fluid flows from the housing 76 which comprise a reservoir 
of a fluid 77 such as saline. Pressure is generated by a piston 
78 driven by threaded rod 80, positioned on a rod support 81, 
recognize that several suitable means for pulling the wire or 
cable are known. For example, the wire or cable can be 
pulled by a hydraulic cylinder or actuator powered by an 
implanted pump or by transcutaneous injection of a fluid, 
such as saline. The wire or cable also could be wound on a 
rotating reel or attached to a lead screw configured to 
produce linear motion, wherein either is powered by electric 
or hydraulic rotary actuators. FIGS. 1 and 2 show two 
opposing piezo-actuators 50 contained in the housing 46 
which can be activated to provide micron-sized step 
advancement of the driven element 52. Wire 36 is attached 
30 pushing the saline from the reservoir out at 83. Alternatively, 
pressure may also be generated by means external to the 
body using a catheter through the skin or by injection into an 
implanted, subcutaneous port. Such ports are commonly 
available. The threaded rod 80 is driven using torque gen-
35 erated by frictional engagement with piezo-actuators 82 or 
by a miniature permanent magnet or other suitable motor. 
Micro Pulse Systems Inc. supplies piezo-actuators suitable 
for use in the device. Driver electronics and a power source 
are indicated as numeral 84. Note that while FIG. 2 shows 
to driven element 52 by a hook 54 or other means so that 
wire 36 is advanced along with driven element 52. Micro 
Pulse Systems, Inc. makes micro-actuators that are suitable 40 
for the device disclosed herein. 
a hydraulic mechanism wherein only strap 10 is moved, the 
hydraulic system may be readily adapted by one of skill in 
the art to exert force on both strap 10 and strap 12. As the actuator 48 pulls the wire 36, the first integrated 
stretch unit 30 is pushed/pulled towards the actuator 48, in 
the direction of arrow 53. The locking straps are thus 
displaced away from each other. 
Alternatively, one skilled in the art could adapt the spring 
driven piston system illustrated in FIG. 9 to provide hydrau-
45 lie power to the embodiment illustrated in FIG. 2. 
The device preferably includes an external driver and 
controller, which are not shown in the Figures. In a preferred 
embodiment, the wire can be activated from outside the 
body once the wire is passed through the skin. Mechanisms 
outside the body are easier to design and transcutaneous 50 
catheters and similar conduits are highly developed. 
The mechanical or hydraulic stretching mechanism works 
to move the straps apart slowly over a period of up to several 
weeks. In one embodiment, the passive driver element 
illustrated in FIG. 9 may be used to provide a pre-
determined stretch over time. In another embodiment, the 
driver may be pre-programmed to operate autonomously, or 
A particularly simple passive device for producing the 
linear motion needed to pull the wire 36 is illustrated in FIG. 
9. The device 180 includes a cylinder 182 having a first 
orifice 184 at one end 181 and a second orifice 186 at the 55 
the driver may be programmed (or reprogrammed) follow-
ing implantation by transcutaneous electromagnetic means, 
based, for example, on x-ray data or other indications of how 
the process is proceeding. The driver may be simply turned 
on or off, or may be programmed or reprogrammed by a other end 183, and containing a movable piston 188, a 
compression spring 190, and working fluid 192. Adjacent 
the one end 181 is an extension 185 of the cylinder 182, 
which contains an absorbent material 194 and includes a 
vent hole 196. The sheath 44 of wire 36 enters the cylinder 
through second orifice 186, and the wire 36 is attached to the 
piston 188 at its center 198. The spring 190, which typically 
is made of stainless steel, titanium or titanium alloy, par-
ticularly nickel-titanium, is in compression and pushes pis-
ton 188 toward first orifice 184, thereby forcing the fluid 
192, typically a biocompatible saline solution, through first 
orifice 184, where it is absorbed by the absorbent material 
magnetic field sensing device such as a reed switch (relay) 
or by other electronic devices or circuits responsive to 
magnetic or electromagnetic fields. The field is generated by 
60 using the external driver control to periodically activate an 
external source positioned to activate the electronic driver 
circuit. The external driver control may be pre-programmed 
to provide a stretch of several centimeters over about one 
month. Alternatively, cyclic stretching of increasing peak 
65 and mean amplitude may be used. Using piezo actuators, 
activating the driver can produce incremental movements of 
the mechanical or hydraulic stretching mechanism as small 
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drug delivery. Alternatively, the balloon can be omitted, and 
the hydrophilic or other volume expanding material can 
simply be placed between the two plates in such a manner 
that exposure to body fluids or another appropriate stimulus 
as a few microns. The prime mover is designed to be force 
limited to preclude overstretching the vessel. Force limita-
tion is inherent if the piezoelectric actuators are used in 
either embodiment and, in the case of permanent magnetic 
motors, can be designed into the electronic driver circuit. 
II. Fixed Attachment Positions 
5 causes the material to expand and fill the area between 
plates. 
III. Combination Fixed/Movable Attachment Positions 
Other embodiments combine rectilinear and curvilinear 
stretching. One such embodiment is a slightly modified 
version of device 90 (shown in FIGS. 5A-C) and is illus-
trated in FIGS. 7A-C. The device 150 includes strip 152, 
that is formed much like strip 94, except that it is formed in 
a slightly curved or angled configuration and includes at 
least one, and preferably several, plates (or tabs) 154, 
In stretching an artery to stimulate angiogenesis, the 
blood vessel portion that is beyond the region where the 
stretching apparatus is attached will be relaxed from its 
normal stretched state and could possibly be relaxed to the 10 
point where it is put in compression, as illustrated in the 
FIGS. 4A and 4B. FIG. 4A illustrates a blood vessel as it is 
normally stretched in vivo, and FIG. 4B illustrates how a 
stretching device having points of contact (X) between 
vessel sections A and B and between A and C. The stretching 
device elongates section A while relaxing sections B and C. 
The consequences of this are unknown, but can be avoided 
15 positioned at or near the long edge of the strip 152 so as to 
form a channel 156. Strip 152 has flexible ends 158 for 
attachment to the blood vessel. A blood vessel is placed in 
channel 156 and attached to the strip 152, like described for if the blood vessel is stretched between two fixed points, as 
described herein. 
One embodiment of the fixed-point device is shown in 20 
FIGS. 5A-C. The device 90 includes two semicircular or 
similarly shaped thin, yet rigid, plates 92 made of or 
completely covered by a biocompatible material, such as 
stainless steel, titanium, titanium alloy, fiber composite, or 
polymer. The plates are separated and connected so as to 25 
remain parallel by a fiat rectangular strip of similar material 
94. The ends of the strip 96 are perforated or otherwise 
formed to accept surgical sutures or other means (e.g., 
adhesive) known in the art to secure a blood vessel to the 
strip at its ends. The ends 96 are also flexible and easily bent, 30 
but without breaking, about axis 98 shown. The device can 
be formed from a single appropriately shaped thin plate. The 
area between the plates contains at least one inflatable 
balloon 100, which may be formed from silicone, rubber, 
elastomeric polymers, or any other highly deformable bio- 35 
compatible material. As the balloon 100 is inflated, it fills the 
space between the two thin plates 92 without significantly 
changing the spacing between the two plates 92, since the 
plates 92 and strip 94 are sufficiently rigid to ensure this. 
Inflation of the balloon 100 can be accomplished using at 40 
least one access port 102, through which a fluid, such as 
saline, is injected, for example, through a needle or catheter 
connected to a syringe or similarly functioning device. The 
inflation process can occur through the skin. The balloon is 
designed and attached to the strip in such a manner that, at 45 
full inflation, it assumes more or less the shape of the space 
between the two plates confining it. 
strip 94, wherein plates 154 serve to hold the blood vessel 
in place. The space between the plates contains one or more 
(three are shown) inflatable balloons 160, which are like 
balloon 100 described above. Inflation of the balloon(s) can 
be accomplished using at least one access port 162, also as 
described above. 
Method for Distending a Blood Vessel 
The distension device can be adapted to operate in vivo or 
in vitro, that is to distend a portion of a blood vessel in vivo 
or following its excision from the body and subsequent 
placement in a medium for cell growth. As used herein, the 
phrase "medium for cell growth" includes any in vitro 
system for facilitating cell division, extra-cellular matrix 
formation, and growth of vessel tissue. For example, the 
distension device can be attached to an excised portion of 
donor vessel and submerged in a medium for cell growth in 
a temperature-controlled container. As described in Example 
1, it has been shown that distension in an organ culture (e.g., 
a bioreactor) significantly stimulates cell division, and can 
be simple to control. See, for example, U.S. Pat. No. 
5,899,936 to Goldstein; U.S. Pat. No. 5,879,875, to Wiggins, 
et al.; and U.S. Pat. No. 5,888,720 to Mitrani, which describe 
techniques for organ and tissue culture which can be adapted 
to the methods described herein. 
I. Operating the Movable Positions Device 
The method for distending a donor blood vessel can 
include attaching a stretching mechanism to the donor vessel 
and operating the stretching mechanism to stretch the donor 
vessel. In one embodiment, the method involves using a 
device wherein a pair of straps are fixedly attached to the 
donor vessel and moved away from one another so that the 
portion of the vessel between the straps is distended. The 
distended portion can then be excised and used as a graft. 
Grafts for coronary by-pass surgery are typically between 
about 10 cm and 15 cm in length, whereas grafts for by-pass 
in the peripheral circulation are typically about 25 cm or 
more in length. Those of skill in the art can readily optimize 
the rate of vessel distension. Distension rates can be linear 
or nonlinear, and may average, for example, between about 
5 and 10 mm/day. 
One embodiment of the method is illustrated in FIG. 3, 
wherein a device (e.g., the one shown in FIG. 1) is attached 
to a donor blood vessel 60. The device can be assembled 
before or at the time of implantation. Straps 10, 12 are 
engaged to encircle the donor vessel and are then sutured in 
An alternative stretching mechanism is provided by 
hydrophilic or chemically reactive synthetic substances 
(e.g., various polymers) or other natural materials (e.g., 50 
cellulose) known to significantly expand their dry volume 
when activated as by exposure to fluid or possibly other 
stimuli (e.g., heat, radiation or various chemical agents). 
Such materials are available in foamed, fiber or other forms, 
any of which may be adapted by one of skill in the art to 55 
effect the balloon inflation described herein. One or more of 
these materials can be placed inside the balloon and 
expanded by the controlled addition of a fluid or chemical 
agent, such as by injection into the balloon, which causes the 
materials to expand, inflating the balloon, in much the same 60 
way as simply pumping saline or another fluid into the 
balloon as described above. The material could also be 
otherwise encapsulated or separated from the stimuli to 
control its means and rate of activation. For example, 
expandable material could be provided with a degradable 
coating or other timed-release mechanism, and such mecha-
nisms can be readily adapted from those used in controlled 
65 place. Push/pull rods 30, 32 are attached to the straps. Wire 
36, and the housing assembly shaft 44, and housing 46 
(containing the actuator) are attached to the device. 
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Preferably, the active prime mover is implanted complete 
with its drive circuit and a minimal power source. 
Alternatively, a passive device, such as described above, can 
be used. As either device is operated, the section of vessel 60 
between the straps 10, 12, indicated by 62, stretches. 
II. Operating the Fixed Positions Device 
5 
The device using fixed attachment positions is preferably 
operated as shown in FIGS. 6A-C, which show a cross-
sectional view (a-a) of the device in FIGS. 5A-C, at 
increasing degrees of vessel distention occurring with 10 
increasing inflation/expansion of the balloon/expanding 
material. In operation, the target blood vessel 93 is placed 
between the two plates 92, resting on the uninflated balloon 
100 (or unexpanded material) and secured to the flexible 
ends 96 of the strip 94, for example by sutures or other 15 
suitable means (FIG. 6A). As the balloon is inflated (or the 
material expanded), the blood vessel 93 is stretched (FIG. 
6B), between the two fixed ends 96 and continues to stretch 
as the space between the two plates is filled (FIG. 6C), 
without the possibility of reducing the tension in or com- 20 
pressing the blood vessel 93 not between the points of 
attachment. 
III. Operating the Combination Fixed/Movable Positions 
Device 
12 
reduce the required length of the salvaged segment. 
Stretched blood vessels can be effectively preserved for 
bypass surgery, for example, using known cryogenic or 
freeze-drying techniques. 
Application of the Distension Devices and Methods 
The present devices and methods are useful for forming a 
vascular graft by axially stretching (i.e. distending or 
extending) a donor blood vessel to stimulate growth. This 
stretching can performed in vivo or in vitro. 
The devices and methods can be sized to stretch blood 
vessels of essentially any size and located in or excised from 
a variety of sites in the body of the patient or donor or 
animal. Preferred blood vessels include, but are not limited 
to, the internal mammary arteries, the gastroepipolic artery, 
the gastric artery, the radial artery, the femoral artery, and the 
splenic artery. Other arteries and veins may also be suitable 
blood vessels for use with the methods and devices. 
In a preferred embodiment of the in vivo distension 
method, the device is implanted, for example using endo-
scopic techniques, in the patient and vessel distension 
effected over a period of time. Then the site of implantation 
is re-exposed, all or a portion of the donor blood vessel 
section (e.g., vessel segment 62 in FIG. 3) is removed and 
the device is explanted. The ends of the donor vessel can 
then be sutured end to end to repair the donor vessel, as is 
commonly done in vascular repair without complication. 
Some blood vessels used for coronary bypass surgery, such 
The device using the combination of fixed and movable 25 
attachment positions is preferably operated as shown in 
FIGS. SA-B. FIG. SA shows a blood vessel attached to the 
device before application of the bending force (i.e. before 
distension). FIG. SB shows the device and blood vessel 
following application of the bending force, wherein strip end 30 as the gastroepipolic and radial arteries, can be removed 
with minimal morbidity such that repair is unnecessary. The 
removed blood vessel section is then ready for use as a graft 
in a patient in need thereof, who preferably is the same 
A is drawn towards strip end B. The device can be, for 
example, device 150 described above. 
In operation, the target blood vessel 153 is first placed in 
the channel formed by plates 154, resting on the uninflated 
balloon 160 and secured to the flexible ends 15S of the strip 35 
152, for example by sutures or other suitable means. The 
ends 15S of the strip 152 are then drawn towards each other 
by mechanical or other forces to cause strip 152 to bend or 
flex, thereby stretching the blood vessel 153. The ends can 
be drawn towards one another by any suitable means, 40 
including a mechanical or magnetic force, or by a differen-
tial expansion effect, for example where the strip consists of 
laminates of materials that contract or expand differently 
from one another when exposed to a stimulus, such as heat 
(thermal expansion) or water (e.g., top layer of strip hydro- 45 
philic while bottom layer hydrophobic). The mechanical 
means can include, for example, the linear or rotary piezo 
micro-motor devices described herein. As the strip 152 is 
bent, distance C increases and distance AB decreases, caus-
ing the section beyond either A or B to be stretched in a 50 
rectilinear manner. 
Additionally, as balloon 160 is inflated (or the material 
expanded), the blood vessel is stretched between the two 
ends 15S and continues to stretch as the space in the channel 
defined by plates 154 is filled. Thus, the section of blood 55 
vessel between ends A and B is stretched in a curvilinear 
manner. The two modes of stretching can occur 
simultaneously, one after another in either order, or any 
combination thereof. 
patient supplying the donor vessel. 
In a preferred embodiment of the in vitro distension 
method, a portion of donor blood vessel (e.g. shorter than 
that needed for a graft) is surgically excised from the patient 
in need of the graft, and then the vessel portion is stretched 
over a period of time in vitro in a medium for cell growth, 
for example, as in a bioreactor. All or a portion of the 
distended vessel is then ready for use as a graft in the patient. 
Where the donor is the recipient of the graft, the result using 
either approach advantageously is a totally autologous, 
living vascular graft. 
Preferred Embodiments 
In a preferred embodiment of the device, the stretching 
mechanism is not actually attached to the blood vessel and 
is therefore easier to use, as no suturing of the device to the 
vessel is required. The device also preferably is enclosed so 
that the possibility of tissue adhesions to soft tissue and/or 
infiltration by body fluids-potential problems with essen-
tially any implanted device-is minimized. The device also 
preferably includes growth factor to stimulate blood vessel 
tissue growth. For in vivo applications, the device also 
preferably is sized and shaped to facilitate minimally inva-
sive implantation, such as by endoscopic insertion. 
In preferred embodiments, a driver element is used to 
IV. In Vitro Operation 60 stretch a blood vessel positioned between two fixed posts. 
Currently, a short segment of blood vessel can be salvaged 
during conventional bypass surgery and an in vitro organ 
culture or bioreactor system can be used to grow sufficient 
graft tissue for a second surgery. Such surgeries represent 
about 30% of all bypass operations. The methods and 65 
devices described herein can be adapted to work with such 
surgeries, to increase the length of graft material and/or to 
Generally, the devices can be designed to have a fixed outer 
shape or, more preferably, to "fold" to yield a reduced profile 
to facilitate insertion (i.e. implantation). 
In all of these preferred embodiments and variations, the 
body preferably is a substantially rigid, elongated structure. 
The devices are designed so that their cross-sectional dimen-
sions facilitate endoscopic implantation, preferably using 
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available hardware. Standard trocars for endoscopic access 
range in size to 25 mm. Device length is influenced by 
choice of artery, length of graft produced, and other factors. 
The expected length is between about 4 cm and 20 cm. 
Non-Fold Design 
In a preferred embodiment, the blood vessel lies between 
two parallel plates, in a configuration similar to the embodi-
ment described above in FIGS. 5 and 6. The basic elements 
and operation of this embodiment of the device is shown in 
FIGS. 10 and 11 which illustrate device 200 in a partially 
exploded view. 
The device 200 includes a base plate 202 and optional 
cover plate 204. The base plate 202 has a first surface 206 
from which a pair of posts 208a and 208b extends. The posts 
208a and 208b each have a lateral surface 209a and 209b, 
which preferably are shaped to accommodate or fit the 
circular cross-sectional shape of the blood vessel being 
stretched. As used herein, the term "post" includes any 
suitable member or structure attached or integral to the 
surface of the plate that has a surface capable of supporting 
the blood vessel during stretching of the vessel. The base 
plate 202 further includes a support member 214 that 
extends from the first surface 206. 
The base plate 202 further includes a moveable driver 
element 210 on the first surface 206, shown in FIG. 10 in its 
resting position on optional resting member 212, which in 
this embodiment is in the form of a rectangular protrusion. 
The driver element 210 is moveable along the first surface 
206 in a direction away from resting member 212, preferably 
along a line perpendicular to a line between the center points 
of posts 208a and 208b, shown as arrow Z. The means for 
moving and controlling the movement of the driver element 
210, which controls the stretching of the blood vessel, are 
described below. 
The cover plate 204 includes a cutout area 205 that has the 
approximate size and shape of the combination of the driver 
element 210 and resting member 212. The cover plate 204, 
which preferably is fiat, is made so that it may be secured to 
the base plate 202, preferably by being attached at the posts 
208a and 208b and at support member 214. Essentially any 
suitable protrusion or other mechanism can be used for 
attaching the cover plate and the base plate together. For 
example, snap type connectors can be fabricated into the 
base plate and/or the cover plate. Such connectors are known 
and routinely used by those skilled in the art. Snap connec-
tors are particularly well suited to structures made with 
biocompatible polymers, for example, in a molding process. 
Representative examples of such polymers include PTFE 
and DELRIN™ (E.I. du Pont de Nemours and Company) 
acetal polymer. 
FIGS. llA-B illustrate how device 200 operates to stretch 
and lengthen a blood vessel. (For clarity, the cover plate 204 
is not shown.) FIG. llA shows blood vessel 220 positioned 
(i.e. threaded) between posts 209a and 209b and driver 
element 210, which is in its initial position. To load the 
device, a length of blood vessel having a length approxi-
mately equal to the distance between the posts 209 is freed 
from the tissue tethering (that is commonly associated with 
mammalian arteries, for example) and then placed into the 
threaded position in the device. FIG. llB shows the blood 
vessel 220 stretched by movement of the driver element 210, 
which has moved away from resting member 212. 
It is desirable to make the stretching device as small as 
possible so that it may be delivered in vivo using standard 
or specially designed endoscopic tools. The elements of this 
embodiment can be fabricated using suitably rigid materials 
and known fabrication methods. Materials such as stainless 
14 
steels, titanium, titanium alloys or biocompatible polymers 
are suitable. Methods for forming the elements of the device 
are well known to those skilled in the art. 
The movement of the driver element can be controlled by 
5 a wide variety of means. In one embodiment, the driver 
element is moved by means of a wire connected to the driver 
element, which pulls or pushes the driver element, thereby 
stretching the blood vessel. One variation of this embodi-
ment is illustrated in FIG. 12, which shows device 200 
10 having driver element 210 attached to wire 250, which is 
enclosed in wire sheath 252. The wire 250 passes through an 
appropriately sized aperture in the resting member 212. 
Such a wire could, for example, be a made of super elastic 
material such as alloys of nickel and titanium. The wire can 
15 be driven by a piezo-actuator or other linear motor, by a 
hydraulic cylinder or actuator powered by an implanted 
pump or by transcutaneous injection of a fluid, by winding 
the wire on a rotating reel or attached to a lead screw 
configured to produce linear motion where either is powered 
20 by electric or hydraulic rotary actuators, or by other suitable 
means for pushing/pulling a wire described above or known 
to those skilled in the art. 
Another means for moving the driven element is illus-
trated in FIG. 13, which shows a base plate 260 from a side 
25 distal the blood vessel and driver elements (not shown). 
Support members 262a and 262b protrude from surface 264 
and support both ends of guide rod 266 secured therebe-
tween. The guide rod 266 is located parallel to and slightly 
spaced apart from the surface 264. The base plate includes 
30 linear slot 268, which extends through the base plate and 
approximately between the support members 262a and 
262b. The centerline of the slot 268 and guide rod 266 if 
shown in FIG. 13 would be identical. Spring 270 is fitted 
over the guide rod 266 and can be expanded or contracted 
35 along its length to move a driver element 272 slidably 
connected to the guide rod 266. 
FIG. 14 illustrates one embodiment of driver element 272, 
wherein guide rod 266 slidingly engages the driver element 
through aperture 273 in distal portion 271 of the driver 
40 element. Flange 274 of the driver element 272 would mate 
with the slot in the baseplate so that the spring can move the 
driver element as needed. The lateral surface 275 of proxi-
mal portion 276 of the driver element would engage the 
blood vessel being stretched. It will be appreciated that 
45 assembly of the driver element, spring, guide rod, and the 
base plate can be facilitated by enlargement of the slot at one 
of its ends to permit the passage of part of the driver element. 
Lateral stability for the driver element can, if needed, be 
provided by the use of mating slots (e.g., grooves) and 
50 protrusions in the base plate (or cover plate or both) and the 
driver element. For example, the base plate could be pro-
vided with one or more small thickness slots (female part), 
which mate with one or more small protrusions the driver 
element, whereby the protrusions of the driver element are 
55 in sliding engagement within the slots of the base plate. An 
example of such a modified driver element is illustrated in 
FIG. 15, which shows driver element 280. The driver 
element 280 includes a male protrusion 282 on one side of 
the element, which could mate with a corresponding slot in 
60 the cover plate of the device. The male protrusions and 
female slots could, of course, be reversed. The lateral 
surface 284 of the driver element would engage the blood 
vessel being stretched. 
The spring/rod mechanism, such as shown in FIG. 13, can 
65 be covered and sealed. For example, the base plate can be 
modified to have a recess in which the mechanism is fit and 
which is enclosed with another plate. As shown in FIG. 16, 
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a base plate 290 is made thicker and with a recess 292. The 
spring/rod mechanism (not shown) fits within the recess and 
16 
Periodic application of electric current can provide the 
dynamic loading as described above. An example of a 
dynamic load produced in this way is the application of 
short-term, large stretching forces produced whenever the 
a third plate 294 can be attached, for example, by using 
appropriate fasteners, adhesive bonding, ultrasonic welding, 
and/or other known fabrication techniques. 5 shape memory material reaches its transition temperature. 
The radii of curvature of surfaces in contact with the 
blood vessel should be as large as possible so that relatively 
large stretching forces can be provided without collapsing 
the blood vessel. Examples of posts shaped for this function 
are illustrated in FIGS. 17A-B. FIG. 17Ashows a post 234 10 
having a curved lateral surface 236 molded into the base 
plate 230, wherein the post extends from a surface 232 of the 
base plate 230. Surface 236 could be, but is not necessarily, 
of constant curvature. FIG. 16B shows a similar post 244 
having a curved lateral surface 246. The post 244 is rotatably 15 
attached to base plate 240 with pin 242, and is free to rotate 
about the axis of the pin 242 and in the plane of the base 
plate 240, as shown by arrow Yin FIG. 17B. In this way, the 
profile of the device can be changed. Specifically, rotation of 
the post 244 can be used to increase the profile of the device 20 
when deployed while maintaining a small profile for the 
device during insertion. This arrangement is useful for 
endoscopic deployment and provides a larger contact sur-
face for the artery when the device is in use. 
FIG. 18 is useful to explain the utility of the optional 25 
cutout 205 in the cover plate 204 shown in FIG. 10. In this 
embodiment, the base plate 300 is designed to temporarily 
hold the driver element 310 in place while the device is 
being prepared for use. This feature is useful because the 
spring may be in compression and would tend to move the 30 
driver element if it were not held, complicating use of the 
device. The resting member 312 extends from the base plate 
300 and has an L-shape as shown in FIG. 18, such that the 
driver element 312 can be secured between the base plate 
and an upper ridge 314 of the resting member 312. The 35 
thickness of the upper ridge 314 would be the same as the 
thickness of the cover plate 204, and the overall shape of the 
resting member 312 would fit flush within the cutout 205 in 
the cover plate 204. A pin 316 passing through an aperture 
in resting member 312 and into a hole in the side of the 40 
driver element 310 can serve to hold the driver element 310 
in place, until it is desired to remove the pin and free the 
driver element to stretch a blood vessel. 
The forces would decrease when the current is removed and 
the wire cools returning the spring to its rest shape. The 
combination of shape change and shape recovery produces 
the desired dynamic, periodic load. Other means of heating 
the wire, such as electromagnetic fields through the skin, are 
also envisioned. Control of the current application can be 
accomplished using devices and methods described herein 
or known to those skilled in the art. 
Yet another way of controlling the movement of the driver 
element is to provide a motor driven cam on which a 
spring-driven driver element can ride. Such an arrangement 
is familiar to those skilled in the art of mechanical system 
design. 
Foldable Design 
These devices are very similar in structure and function as 
the non-fold versions described above, except that these 
devices advantageously can "fold" to yield a smaller, nar-
rower cross-sectional profile to facilitate minimally invasive 
in vivo insertion, preferably using standard, off-the-shelf 
endoscopic hardware. These embodiments also make pos-
sible devices having a wide range of aspect (length/width) 
ratios. This characteristic is important because it affects how 
much (i.e. the length) a blood vessel can be grown, as well 
as the size of the forces that can be applied to the blood 
vessel during the stretching process. 
One preferred embodiment of such a device is illustrated 
in FIG. 19. FIG. 19 shows device 400 in its deployed 
configuration with a blood vessel 450. The device 400 
includes a cylindrically shaped body 402, which preferably 
houses the electromechanical or other means of moving the 
driver element 404 along slot 406. The mechanism for 
moving the driver element 404 can include any of the 
various means for producing the requisite linear motion that 
are described herein or known to those skilled in the art of 
mechanical design. It can be seen that as the driver element 
404 moves up, the blood vessel 450 is stretched transverse 
to its length. The distal end 452 and proximal end 454 of the 
blood vessel 450 are tethered by the tissue naturally sur-
rounding blood vessel 450, but may be further anchored In any of these embodiments utilizing a spring to supply 
the driving force, it will be appreciated that such a spring can 
be designed in a number of different ways depending on the 
desired force characteristic. An ordinary spring would pro-
vide constant stretch. A spring having a nonlinear or a 
constant force-deformation response could also be used. Yet 
another alternative is a spring fabricated of shape memory 
materials so that its stiffness or shape can be changed as 
stretching progresses or periodically. Such a spring could act 
45 using sutures or other means of fixation, as appropriate, at 
the distal and proximal ends. Device 400 further includes 
arms 408a and 408b, which extend from and are hinged at 
the lower end portion 409 of the body 402. Wheels 4 lOa and 
410b (which function like the posts in the non-fold design) 
50 are rotatably attached to the ends of arms 408a and 408b, 
respectively, distal the body 402. 
in series or parallel with another spring designed as 
described above. Shape memory materials can change their 
shape in response to changes in their temperature. Nickel- 55 
titanium alloys, which exhibit super-elastic and shape-
memory effects, are particularly suitable. Shape memory 
nickel-titanium alloys and certain polymeric materials can 
be fabricated to change shape from straight to curved as the 
material changes temperature. Examples of shape memory 60 
polymers are described, for example, in PCT WO 99/42528 
and U.S. Pat. No. 6,160,084, which are incorporated herein. 
This effect can be used to provide dynamic loading of the 
blood vessel by using heating means to heat the spring to 
change its temperature and thus its shape and/or stiffness. 65 
For example, the heating could be resistive heating of the 
spring by electric current (e.g., from a battery or capacitor). 
FIGS. 20A-B show the device in its "folded" 
configuration, i.e. before deployment, in a side view (FIG. 
20A) and in a front view (FIG. 20B). As can be seen, the 
arms 408a/b and wheels 410a/b fold down so as to reduce 
the cross-sectional profile of device 400 so that it can be 
more readily inserted through a standard endoscopic trochar. 
Once inserted, the arms 408a/b and wheels 410a/b can be 
deployed as shown in FIG. 19. 
A wide variety of mechanisms to effect the folding and 
deployment can be devised by those skilled in the art of 
mechanical design. FIGS. 19 and 20 can be used to describe 
one such scheme. In this scheme, the lower end portion 409 
of the body 402 is made so that it has two "locked" 
configurations. One is shown in FIGS. 20A and 20B and the 
other, representing a ninety degree axial rotation of the lower 
end portion 409, is shown in FIG.19. When in either of these 
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Other Features of Either Design 
The methods and devices described herein optionally can 
include growth factors or other growth stimulating agents 
(e.g., hormones) to further enhance blood vessel growth. For 
two "locked" configurations, the lower end portion 409 
resists rotation about the longitudinal axis of the body 402. 
Such resistance can be provided, for example, by a protru-
sion from the lower end portion into mating intrusions into 
the cylindrical body of the device. The lower end portion 
409 also is designed so that it can move in the axial 
direction, away from the body 402, as shown by arrow K. 
This can be achieved by a central round shaft in the body 402 
of the device 400 and a mating central hole in the lower end 
portion 409, wherein the lower end portion 409 is spring 
loaded in the axial direction so that any axial movement in 
direction of arrow K tends to be recovered as the lower end 
portion 409 tries, under spring load, to return the spring 
towards equilibrium by moving in direction shown by arrow 
L. When in either one of the two locked configurations, the 
lower end portion 409 is prevented from rotating about the 
axis of the device by the protrusion and mating intrusions 
previously described. Such protrusion and intrusions would 
5 example, such growth stimulating agents can be delivered to 
the blood vessel by impregnating the materials forming the 
device or by providing a suitable coating or reservoirs in the 
device that can contain and controllably release such agents 
during the extension process. Examples of such growth 
10 factors include vascular endothelial growth factor (VEGF), 
endothelial cell growth factor (ECGF), basic fibroblast 
growth factor (bFGF), and platelet derived growth factor 
(PDGF). Biocompatible polymeric materials for controlled 
release that are known in the art for drug delivery (see e.g., 
15 U.S. Pat. No. 5,879,713 to Roth et al.) can be adapted for use 
with the devices described herein. The devices and methods 
be of a length and depth, respectively, that when the lower 
end portion 409 is moved axially, it could, if moved 20 
sufficiently, be freed of its axial rotational lock. When so 
freed, the lower end portion 409 can be freely rotated about 
the axis of the body 402. Upon rotation to either the 
configuration shown in FIG. 19 or 20Aor 20B, the lower end 
portion 409 can again be rotationally locked. This occurs 25 
when the spring induced axial motion (in the direction of 
arrow L) results in the interlocking of the aligned protrusion 
with one of the other of the intrusions. 
The lower end portion 409 includes upper slots 412 and 
lower slots 414. There are two slots here, but the device 30 
could also be designed with one continuous slot, or with 
more than two slots, if desired. After insertion of device 400 
into a donor patient, the arms 408a/b (with wheels 410a/b) 
are free to move about their hinged connection to lower end 
portion 409, in the direction of the curved arrows M shown 35 
in FIG. 20A, toward and into their deployed position shown 
in FIG. 19. This causes the arms 408a/b to move into slots 
414. Once the arms 408a/b are horizontal (i.e. perpendicular 
also can be used in combination with external electric, 
magnetic, or electromagnetic fields applied as a growth 
stimulus (see e.g., U.S. Pat. No. 4,846,181 to Miller). 
The devices also can optionally include appropriate drugs 
(e.g., therapeutic or prophylactic agents) impregnated into or 
coated to structural components, for example to minimize 
infections, inflammatory reactions, scar tissue formation, 
adhesion formation, and/or other adverse tissue reactions. 
For example, where tissue growth is to be avoided, certain 
antifibrotic agents may be present, such as 5-fluourouracil or 
mitomycin. The device may be more generally provided 
with coatings that are antibiotic or anti-inflammatory. 
The devices also can be enclosed in a suitable sheath to 
limit adhesion formation and/or infiltration by body fluids 
while implanted in vivo, or be impregnated or coated with 
materials selected to reduce adhesion formation as known in 
the art. Examples of such coating materials include, but are 
not limited to, parylene, polytetrafluoroethylene (e.g., 
TEFLON™) and chromium (e.g., ME-92™, Armoloy 
Corp.), which can be used to coat a variety of other metal 
and polymer substrates. 
The devices and methods of use thereof described herein 
are further described by the following non-limiting to the axis of the body 402), the lower end portion 409 can 
be moved axially, unlocked, rotated ninety degrees, and 
released and re-locked as described above. In so doing, slots 
412 will lock the arms 408a/b in place, as shown in FIG. 19. 
Once the arms 408a/b are locked, the device 400 is ready for 
blood vessel loading and stretching. 
40 examples. 
The device 400 preferably includes suitable top and 45 
bottom plates (not shown in FIG. 19) that isolate, as much 
as possible, the device from the surrounding tissue and body 
fluids and minimize the mechanical influences of external 
forces that might tend to move the device. FIG. 21 illustrates 
one embodiment of a bottom plate 420. The plate can 50 
sutured or otherwise held in place by various means of 
attachment. FIG. 21 shows the plate 420 with sutures 422. 
The plate 420 further includes snaps 424 for attaching the 
plate 420 to the back of the body of a device, such as that 
of FIG. 19. Other attachment means, such as tapped holes, 55 
threaded protrusions, or other fasteners can be used to 
connect the bottom plate (and the top plate) to the body of 
the device. 
EXAMPLE 1 
In Vivo Vessel Stretching to Stimulate Cell 
Division 
Leung et al., Science 191:475-77 (1976) showed that 
cyclic stretching stimulates synthesis of matrix components 
in arterial smooth muscle cells in-vitro. Subsequent studies 
in arterial tissue have been limited to the effects stretching 
on cells attached to a membrane in cell culture (see, for 
example, Birukov, et al., Molecular & Cellular Biochem. 
144:131-39 (1995); Costa, et al., FASEB J. 5:A1609-7191 
(1991)) or in a vascular graft construct (Kanda, et al., Cell 
Transplantation 4(6):587-95 (1995)). No known studies, 
however, have analyzed the effect of stretch on cells in intact 
vessel walls. Therefore, a study was made of porcine carotid 
arteries in an organ culture system developed by Conklin 
(Conklin, B. Viability of Porcine Common Carotid Arteries 
in a Novel Organ Culture System MS Thesis, Georgia When implanting the device, a tool, such as tool 430 in 
FIG. 21, can be used to stretch a blood vessel 450 over 
wheels 410 in the direction of arrow N, thereby properly 
seating the blood vessel 450 in the device. (Note that only 
the wheels of the device are shown in FIG. 21.) The device 
then can be secured to the bottom plate. Once the bottom 
plate and device are in place, a suitable top plate can be 
installed so that the device is, to the extent possible, isolated 
from its surroundings. 
60 Institute of Technology, 1997), in order to determine the 
effect of axial stretching on smooth muscle cell division in 
an intact vessel. See also Han, H. C. , Vito, R. P. , Michael, 
K., Ku, D. N., "Axial Stretch Increases Cell Proliferation in 
Arteries in Organ Culture", Advances in Bioengineering, 
65 ASME, BED 48:63-64 (2000). 
Left and right external carotid arteries were obtained at 
slaughter, one for testing and the other serving as a control. 
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Both vessels were immersed in cell culture media containing 
DMEM (Sigma Dll 52), sodium bicarbonate (3.7 g/L, 
Sigma), L-glutamine (2 mM, Sigma), antibiotic-antimycotic 
solution (10 ml/L, Gibco), and calf serum (CS 10%, 
Integren). The vessels were perfused with the same media 5 
with the addition of Dextran (5% by weight, MW 282,000 
Sigma). The test and control specimen both were maintained 
at body temperature and subjected to pulsatile flow in the 
physiological range. The control specimen was restored to 
and maintained at the in-vivo length, which corresponds to 10 
a stretch ratio of 1.5, for the duration of the experiment. The 
test specimen was stretched an additional 30% to a stretch 
ratio of 1.8 over the first two and one-half days of the five 
day experiment. 
Bromodeoxyuridine ("BRDU") staining was used to com- 15 
pare the number of cells that were dividing in the test and 
control specimens. On the fifth day, the specimens were 
pressure-fixed with formalin and histologic slides prepared 
for cell counting using light microscopy. The BRDU was 
added on day four and the test specimen showed that 20 
6.8+/-2.8% of the cells were dividing, while only 3.08+/-
2.9% of the cells were dividing in the control specimen. The 
results clearly suggest that axial stretching can be used to 
enhance cell division in blood vessels, and should therefore 
be useful in the growing vessel segments for use in creating 25 
blood vessel grafts. 
Modifications and variations of the present invention will 
be obvious to those of skill in the art from the foregoing 
detailed description. Such modifications and variations are 
intended to come within the scope of the following claims. 30 
We claim: 
1. A device for axially extending a blood vessel to induce 
growth of the blood vessel, comprising: 
a stretching mechanism which comprises 
(i) a rigid body; 
(ii) a pair of posts comprising a first post and a second 
post which are connected to the body; 
(iii) a driver element slidably secured to the body and 
disposed between the pair of posts; and 
35 
(iv) a means for sliding the driver element away from 40 
the pair of posts to axially distend a blood vessel 
positioned between the pair of posts and the driver 
element. 
20 
8. The device of claim 7, further a pin which is removably 
inserted through an aperture in the resting member and into 
a hole in the driver element to hold the driver element in 
place before vessel loading and stretching. 
9. The device of claim 1, further comprising a pair of 
movable arms connecting the pair of posts to the body. 
10. The device of claim 9, wherein the pair of moveable 
arms comprise a first arm and a second arm, each arm having 
a distal end and a proximal end, such that the proximal ends 
are hingedly connected to the body. 
11. The device of claim 10, wherein the posts are wheels 
that are rotatably attached to the distal end of each arm. 
12. The device of claim 9, wherein the body comprises a 
lower end portion which is adjustable to lock the moveable 
arms into two or more positions. 
13. The device of claim 12, wherein the lower end portion 
is biased by a spring to hold the lower end portion in 
engagement with the body. 
14. The device of claim 13, wherein the lower end portion 
is rotatable about and moveable along the longitudinal axis 
of the body. 
15. The device of claim 1, further comprising a controller 
for controlling the means for sliding the driver element. 
16. The device of claim 15, wherein the means for sliding 
can move the driver element in a continuous manner. 
17. The device of claim 15, wherein the means for sliding 
can move the driver element in an intermittent manner. 
18. The device of claim 15, wherein the means for sliding 
can move the driver element in a cyclical manner. 
19. The device of claim 1, wherein the means for sliding 
the driver element comprises a primer mover that is 
mechanically, electromechanically, or hydraulically driven. 
20. The device of claim 1, further comprising a guide rod 
which passes through an aperture in the driver element to 
guide the movement of the driver element as the drive 
element is slid along the guide rod by the means for sliding. 
21. The device of claim 1, wherein the driver element 
comprises a protrusion or groove which matingly engages 
with a corresponding groove in or protrusion from the body 
to guide the movement of the driver element as the drive 
element is slid by the means for sliding. 
2. The device of claim 1, wherein the body comprises a 
first plate having a proximal surface and a distal surface, and 
the pair of posts is attached to the proximal surface in a fixed 
position. 
22. The device of claim 1, wherein the posts each have a 
45 curved lateral surface having a radius of curvature large 
enough to avoid collapsing the blood vessel during stretch-
3. The device of claim 2, further comprising a second 
plate having a proximal surface and a distal surface, wherein 
the second plate is secured to the body such that the 50 
proximal surface of the first plate is in a position parallel to 
the proximal surface of the second plate and defining a space 
therebetween in which the blood vessel can be stretched. 
4. The device of claim 3, wherein the pair of posts are 
located near or at a first edge of the proximal surface of the 55 
first plate, and further comprising one or more spacer 
elements attached to the proximal surface of the first plate 
near or at a second edge distal the first edge. 
ing. 
23. The device of claim 1, wherein the means for sliding 
the driver element comprises one or more springs. 
24. The device of claim 23, wherein the springs comprise 
a shape memory material. 
25. The device of claim 1, further comprising a growth 
stimulating agent which can be released in an effective 
amount to enhance growth of the blood vessel. 
26. The device of claim 1, wherein all or a portion of the 
device is radioopaque. 
27. A method for distending a donor blood vessel of a 
human or animal to induce blood vessel growth, using the 
device of claim 1, comprising the steps: threading a portion 5. The device of claim 2, wherein the posts are each 
integral with the proximal surface of the first plate. 
6. The device of clam 2, wherein the posts are each 
rotatably attached to the proximal surface of the first plate. 
60 of a blood vessel between the pair of posts and the driver 
element; and sliding the driver element away from the pair 
of posts to axially stretch the blood vessel over a period of 
time effective to induce axial growth of the blood vessel. 7. The device of clam 2, further comprising a resting 
member extending from the proximal surface of the first 
plate, wherein the resting member is shaped such that the 65 
driver element can be secured between the proximal surface 
and an upper ridge of the resting member. 
28. The method of claim 27, wherein the stretching occurs 
lil VIVO. 
29. The method of claim 27, wherein the stretching occurs 
in vitro in a medium for cell growth. 
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30. The method of claim 27, wherein the means for sliding 
the driver element slides the driver element in a continuous 
manner. 
31. The method of claim 27, wherein the means for sliding 5 
the driver element slides the driver element in an intermit-
tent manner. 
22 
33. A method for forming a vascular graft for a human or 
animal in need thereof, comprising: distending a donor 
blood vessel of a human or animal to induce blood vessel 
growth using the device of claim 1, comprising the steps: 
threading a portion of a blood vessel between the pair of 
posts and the driver element; and sliding the driver element 
away from the pair of posts to axially stretch the blood 
vessel over a period of time effective to induce axial growth 
of the blood vessel; and excising a portion of the distended 32. The method of claim 27, wherein the blood vessel is 
selected from the group consisting of an internal mammary 
artery, a femoral artery, a gastroepipolic artery, a radial 
artery, and a splenic artery. 
10 donor vessel, said portion thereby providing a vascular graft. 
* * * * * 
